Mark Albertella

Mark Albertella is an experienced professional in the biopharmaceutical industry with a focus on oncology and drug discovery. As of October 2021, Mark holds the position of Senior Director of Oncology Bioscience at AstraZeneca, following roles such as Vice President of Translational Oncology at STORM Therapeutics Limited and Director of Biology at Medivir AB. With a background that includes leadership positions at OSI Pharmaceuticals and KuDOS Pharmaceuticals, Mark has overseen multiple drug discovery initiatives and managed teams of scientists across various projects. Educationally, Mark received a BSc (Hons) in Biochemistry and Genetics from the University of Leeds and a D Phil in Biochemistry from the University of Oxford.